…you actually think Merck wouldn't spend a few million more and file an NDA because they're waiting solely on OS? C'mon, seriously. They're going to file either way.
I agree with jq1234. In fact, I would go a step further and opine that, whether or not MRK ultimately decides to file, this NDA is not approvable without at least a positive trend in the OS data.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”